| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
05-19-2008, 03:52 PM
|
#1 | |||
|
||||
|
Magnate
|
GSK Launches ReQuip XL(R) (ropinirole Prolonged-release Tablets) A New Once Daily Formulation For The Treatment Of Parkinson's Disease
Article Date: 19 May 2008 - 1:00 PDT GlaxoSmithKline (GSK) have announced the launch of a new treatment for Parkinson's disease (PD) in the UK. ReQuip XL® (ropinirole prolonged-release tablets) is the UK's first and only once-daily non-ergot oral dopamine agonist available for the treatment of PD1, providing continuous delivery of ropinirole from a single daily dose2. Ropinirole prolonged-release is approved for the treatment of idiopathic Parkinson's disease (Monotherapy and Adjunct Therapy) in patients already taking ropinirole immediate release tablets and in whom adequate symptomatic control has been established1. READ more...
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
|
 Reply With Quote
|
|
05-20-2008, 12:39 PM
|
#2 | |||
|
||||
|
Senior Member
|
Why did the UK get to launch this extended-release treatment and the US FDA said no??? Does anybodoy get it?
Peg |
|||
|
|
Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Starting Requip | Multiple Sclerosis | |||
| Rebif's new formulation improves tolerability | Multiple Sclerosis | |||
| NEWS: New Study...24-Hour Formulation of Requip | Parkinson's Disease | |||
GSK Launches ReQuip XL(R) Once Daily Formulation For The Treatment Of PD
Linear Mode
